Who
Ryan Lynch
Officer
Company insider
Files Form 4 as: Officer, Crescent Biopharma; Pao, Concert Pharmaceuticals.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $76K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 6 Jul 2017
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $4,296240 at $17.90 | filing |
| 16 Sep 2026filed 18 Sep 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $4,296240 at $17.90 | filing |
| 22 Jun 2026filed 23 Jun 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $8,365465 at $17.99 | filing |
| 22 Jun 2026filed 23 Jun 2026 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Sold | $8,365465 at $17.99 | filing |
| 15 Dec 2025filed 17 Dec 2025 | CBIO Crescent Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,512 at $0.00 | filing |
| 15 Dec 2025filed 17 Dec 2025 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Code A | —8,378 | filing |
| 15 Dec 2025filed 17 Dec 2025 | CBIO Crescent BiopharmaBiotechnology | SEC FORM 4 Code A | —4,000 | filing |
| 15 Aug 2019filed 19 Aug 2019 | Concert Pharmaceuticals | SEC FORM 4 Code A | —14,063 | filing |
| 31 Mar 2019filed 2 Apr 2019 | Concert Pharmaceuticals | SEC FORM 4 Code F | $13K1,043 at $12.07 | filing |
| 4 Jan 2019filed 8 Jan 2019 | Concert Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —6,100 at $0.00 | filing |
| 31 Mar 2018filed 3 Apr 2018 | Concert Pharmaceuticals | SEC FORM 4 Code F | $22K961 at $22.90 | filing |
| 4 Jan 2018filed 8 Jan 2018 | Concert Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —4,950 at $0.00 | filing |
| 14 Sep 2017filed 18 Sep 2017 | Concert Pharmaceuticals | SEC FORM 4 Code M | $33K3,500 at $9.46 | filing |
| 14 Sep 2017filed 18 Sep 2017 | Concert Pharmaceuticals | SEC FORM 4 Sold | $51K3,500 at $14.51 | filing |
| 14 Sep 2017filed 18 Sep 2017 | Concert Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —3,500 at $0.00 | filing |
| 6 Jul 2017filed 10 Jul 2017 | Concert Pharmaceuticals | SEC FORM 4 Code A | —6,000 | filing |
News
No headline names them, or the companies they trade most, lately.